Innate Pharma (IPHA)
(Delayed Data from NSDQ)
$2.21 USD
-0.05 (-2.21%)
Updated Aug 23, 2024 03:59 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | NA |
---|---|
Current Quarter | NA |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -0.94 |
Next Year | -0.84 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 24.51M | 27.63M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 24.51M | 27.63M |
Low Estimate | NA | NA | 24.51M | 27.63M |
Year ago Sales | NA | NA | 66.71M | 24.51M |
Year over Year Growth Est. | NA | NA | -59.67% | 12.73% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -0.94 | -0.84 |
# of Estimates | NA | NA | 2 | 2 |
Most Recent Consensus | NA | NA | -0.94 | -0.84 |
High Estimate | NA | NA | -0.66 | -0.57 |
Low Estimate | NA | NA | -1.22 | -1.11 |
Year ago EPS | NA | NA | -0.10 | -0.94 |
Year over Year Growth Est. | NA | NA | -840.00% | 10.64% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 0 | 0 |
Up Last 60 Days | NA | NA | 0 | 0 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 0 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -0.94 | -0.84 |
7 Days Ago | NA | NA | -0.94 | -0.84 |
30 Days Ago | NA | NA | -0.94 | -0.84 |
60 Days Ago | NA | NA | -0.94 | -0.84 |
90 Days Ago | NA | NA | -0.94 | -0.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -0.94 | -0.84 |
Zacks Consensus Estimate | NA | NA | -0.94 | -0.84 |
Earnings ESP | NA | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | NA | NA | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more